Advanced search
Companies (65)
The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...
Capitalization | 46 642 M USD |
---|---|
Change | -0.45% |
1-year price change | -11.46% |
The Estée Lauder Companies Inc. is one of the 1st world cosmetics groups. Products are sold under brands (Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le La ...
Capitalization | 46 642 M USD |
---|---|
Change | -0.44% |
1-year price change | -7.79% |
Capri Holdings Limited is a holding company, which owns brands that are designers, marketers, distributors and retailers of womenâs and menâs accessories, footwear and ready-to-wear bearing the Versace, Jimmy Choo and Michael Kors tradenames and relat ...
Capitalization | 4 165 M USD |
---|---|
Change | +3.44% |
1-year price change | -26.43% |
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directe ...
Capitalization | 5 014 M USD |
---|---|
Change | -7.48% |
1-year price change | -5.80% |
Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...
Capitalization | 35 696 M USD |
---|---|
Change | +1.55% |
1-year price change | +16.18% |
Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product ...
Capitalization | 12 303 M USD |
---|---|
Change | -3.91% |
1-year price change | +42.32% |
Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), ...
Capitalization | 1 529 M USD |
---|---|
Change | -0.41% |
1-year price change | -5.70% |
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (C ...
Capitalization | 150 M USD |
---|---|
Change | -2.25% |
1-year price change | -24.31% |
Nash Dom Bulgaria Holding AD Sofia (Nash Dom-Bulgaria AD-Holding or Nash Dom Bulgaria Holding PLC) is a Bulgaria-based holding company that is principally engaged in the acquisition, appraisal and managing of shares in companies active in the food process ...
Capitalization | 182 723 USD |
---|---|
Change | +17.31% |
1-year price change | -.--% |
Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH ...
Capitalization | 181 M USD |
---|---|
Change | 0.00% |
1-year price change | -4.11% |
- Stock Market
- Advanced search
- Michael Nash
- Company Profiles